Principal Display Panel (150 mg Tablet Container)
Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 16729-444
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 16729-444). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (300 mg Tablet Container)
This is a medication called ZYBAN® that contains 300mg bupropion hydrochloride USP in an extended-release tablet. It is usually taken once daily, according to prescribed instructions. The medication should be stored between 15°C and 30°C, protected from light, and preserved in a well-closed container. It is manufactured by Accord Healthcare, Inc. and comes with a medication guide to be given to each patient. The text also includes the NDC code and information about the manufacturer.*
Wellbutrin Chemical Structure (Bupropion Structure)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
